EVerZom

Paris, France

EVerZom is a nanomedicine biotech company providing a large scale of GMP manufacturing platform of extracellular vesicles.

$11.6M raised

Oct 2025

Series A

Top Investors

BpifranceEuropean Innovation CouncilEuropean Innovation Council FundCapital CellCapital Grand Est

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has EVerZom raised?

EVerZom has raised $11.6M in total funding. The most recent round was Series A. The last funding was announced in October 2025.

Who are EVerZom's investors?

EVerZom's investors include Bpifrance, European Innovation Council, European Innovation Council Fund, Capital Cell, Capital Grand Est.

Where is EVerZom headquartered?

EVerZom is headquartered in Paris, France.

What does EVerZom do?

EVerZom is a nanomedicine biotech company providing a large scale of GMP manufacturing platform of extracellular vesicles.

What stage is EVerZom at?

EVerZom is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 14, 2025.

MLA

"EVerZom — Funding & Investors." VCBacked, October 14, 2025, https://www.vcbacked.co/company/everzom. Accessed June 4, 2026.

APA

VCBacked. (2025). EVerZom — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/everzom

Wikipedia (cite web)

{{cite web |title=EVerZom — Funding & Investors |url=https://www.vcbacked.co/company/everzom |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 14, 2025.